Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
Sharat Chandra, MD |
IDF Severe Combined Immunodefi |
Health Resources & Services Admin/University of California, San Francisco |
12689sc |
8/1/20-7/31/22 |
$12,000 |
Anthony J Sabulski, MD |
Mechanisms and Consequences of |
Thrasher Research Fund |
Sabulski, Anthony, T |
1/1/22-12/31/22 |
$12,039 |
Kasiani C Myers, MD |
Systems Biology of Bone Marrow |
National Institutes of Health (NIH)/Children's Hospital Boston |
GENFD0001792995 |
7/1/21-6/30/22 |
$13,423 |
Jacob Bleesing, MD-PHD |
PRIMARY IMMUNE DEFICIENCY TREA |
National Institutes of Health (NIH)/The Univ of California, San Francisco |
8404sc |
9/1/21-8/31/22 |
$16,350 |
Kasiani C Myers, MD |
BMT CTN 1904 |
National Institutes of Health (NIH)/National Marrow Donor Program |
1904 |
7/1/21-6/30/26 |
$18,093 |
Stella M Davies, MD |
Molecular mechanisms for bone |
National Institutes of Health (NIH)/Northwestern University Medical School |
60052734 CCHMC |
2/1/21-1/31/22 |
$21,684 |
Pooja Khandelwal, MD |
Development and Psychometric T |
National Institutes of Health (NIH)/Westat, Inc |
75N91020F00087 |
5/1/20-4/30/24 |
$23,500 |
Ruby Khoury, MD |
A Multi-Center, Phase II Trial |
National Marrow Donor Program |
C10146 |
6/1/21-5/31/26 |
$23,556 |
Sharat Chandra, MD |
Identifying Novel CSF Biomark |
Histiocytosis Association of America |
Chandra, S., HAA |
1/1/22-12/31/22 |
$50,000 |
Jeremy D Rubinstein, MD-PHD |
Viral specific T-cells as anti |
St. Baldrick's Foundation |
Rubinstein, J., St. |
7/1/21-6/30/22 |
$95,250 |
Anthony J Sabulski, MD |
Mechanisms and Markers of Graf |
Hyundai Hope on Wheels |
Sabulski, A., HHOW |
12/1/21-11/30/22 |
$100,000 |
Stella M Davies, MD |
MIDAS: Microangiopathy, Endoth |
National Institutes of Health (NIH)/The Ohio State University Research Fnd |
60078812 |
8/1/21-7/31/22 |
$139,160 |
Stella M Davies, MD |
Childhood Cancer Survivor Study |
National Institutes of Health (NIH)/St Jude's Children's Hospital |
111287260-7914878 |
12/1/20-11/30/21 |
$152,707 |
Stella M Davies, MD |
Host and viral determinants of |
National Institutes of Health (NIH)/Children's Hospital of Philadelphia |
TBD |
7/1/21-6/30/22 |
$285,783 |
Stella M Davies, MD |
Randomized trial of viral spec |
National Institutes of Health (NIH) |
U01AI157620 |
5/1/22-4/30/23 |
$354,337.50 |
Parinda Mehta, MD |
Quercetin Chemoprevention for |
Food and Drug Administration |
R01FD006353 |
7/1/21-6/30/22 |
$431,437 |
Zackary Cleveland, PHD |
Imaging and Molecular Phenotyp |
National Institutes of Health (NIH) |
RHL151588A |
2/3/21-1/31/22 |
$562,685 |
Assem Ziady, PHD |
Commercial Translation of Biom |
National Institutes of Health (NIH) |
R61HL154105 |
12/1/21-7/31/23 |
$572,829 |
Sonata Jodele, MD |
Thrombotic microangiopathy (TM |
National Institutes of Health (NIH) |
R01HD093773 |
9/1/21-8/31/23 |
$674,875 |
Stella M Davies, MD |
TRANSPIRE: A Prospective Cohor |
National Institutes of Health (NIH) |
1R01HL157392-01 |
9/1/21-5/31/22 |
$742,257 |
Assem Ziady, PHD |
Predictive Molecular Markers o |
National Institutes of Health (NIH) |
R01HL142210 |
4/1/22-3/31/23 |
$833,651 |
Kasiani C Myers, MD |
Penetrating the "Black box": |
National Institutes of Health (NIH) |
R01HL153108 |
5/1/22-4/30/23 |
$1,269,671 |
Total Annual Grant Award Dollars |
$6,405,287.50 |